Literature DB >> 8439194

Screening for toxoplasmosis during pregnancy.

C S Peckham1, S Logan.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8439194      PMCID： PMC1029156          DOI： 10.1136/adc.68.1_spec_no.3

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  13 in total

1.  Methods for estimating the incidence of primary infection in pregnancy: a reappraisal of toxoplasmosis and cytomegalovirus data.

Authors:  A E Ades
Journal:  Epidemiol Infect       Date:  1992-04       Impact factor: 2.451

2.  Toxoplasma gondii antibodies in pregnant women in Stockholm in 1969, 1979, and 1987.

Authors:  M Forsgren; E Gille; I Ljungström; D J Nokes
Journal:  Lancet       Date:  1991-06-08       Impact factor: 79.321

3.  Report from the British Paediatric Surveillance Unit.

Authors:  S M Hall; M Glickman
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

Review 4.  Congenital toxoplasmosis. A long-term follow-up of 20 years.

Authors:  J G Koppe; A Rothova
Journal:  Int Ophthalmol       Date:  1989-12       Impact factor: 2.031

5.  Congenital toxoplasmosis: to screen or not to screen?

Authors:  A W Joss; J M Chatterton; D O Ho-Yen
Journal:  Public Health       Date:  1990-01       Impact factor: 2.427

6.  Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases.

Authors:  F Daffos; M Capella-Pavlovsky; F Forestier
Journal:  Am J Obstet Gynecol       Date:  1985-11-15       Impact factor: 8.661

7.  Prenatal diagnosis of congenital toxoplasmosis.

Authors:  G Desmonts; F Daffos; F Forestier; M Capella-Pavlovsky; P Thulliez; M Chartier
Journal:  Lancet       Date:  1985-03-02       Impact factor: 79.321

8.  Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection.

Authors:  J Couvreur; G Desmonts; P Thulliez
Journal:  J Antimicrob Chemother       Date:  1988-07       Impact factor: 5.790

9.  Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection.

Authors:  C B Wilson; J S Remington; S Stagno; D W Reynolds
Journal:  Pediatrics       Date:  1980-11       Impact factor: 7.124

Review 10.  What is known about the prevention of congenital toxoplasmosis?

Authors:  D Jeannel; D Costagliola; G Niel; B Hubert; M Danis
Journal:  Lancet       Date:  1990-08-11       Impact factor: 79.321
View more
  4 in total

Review 1.  Surveillance for rare disorders by the BPSU. The British Paediatric Surveillance Unit.

Authors:  C Verity; M Preece
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

2.  Rare disease surveillance: An international perspective.

Authors:  E J Elliott; A Nicoll; R Lynn; V Marchessault; R Hirasing; G Ridley
Journal:  Paediatr Child Health       Date:  2001-05       Impact factor: 2.253

3.  Diagnostic implications of kinetics of immunoglobulin M and A antibody responses to Toxoplasma gondii.

Authors:  M Gorgievski-Hrisoho; D Germann; L Matter
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

Review 4.  The Importance of Use of the On-line Databases as a Source for Systematic Review of Toxoplasmosis Screening During Pregnancy.

Authors:  Chrysa Voyiatzaki; Christos Orovas; Maria Trapali; Dimitrios I Chaniotis; Anastasios G Kriebardis; Apostolos Beloukas; Nikolaos D Thalassinos; Eirini Orovou; Georgios Iatrakis; Evangelia Antoniou
Journal:  Acta Inform Med       Date:  2021-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.